NovAccel.
株式会社NovAccel（ノバセル）
Japan · $5.0M raised
- Business Model
- B2B
- Website
- novaccel.jp
- Total Funding
- $5.0M
- Last Round
- Venture RoundMay 2026
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Commercial production and supply of the medical radioisotope actinium-225 using a proprietary compact superconducting accelerator
Summary
NovAccel. is a Biotech company based in Japan. It has raised $5.0M in total across 2 rounds, most recently a Venture Round in May 2026. Investors include UTEC - The University, Fast Track Initiative, and Daiwa Corporate Investment.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2026
Sign up to see all 2 events
Funding: Seed through Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/novaccel"><img src="https://indexed.vc/api/badge/company/novaccel" alt="NovAccel. on Indexed.vc" width="260" height="76" /></a>